Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, Penzone P, Lombardi J, Dunn P, Cohn DE, Copeland L, Eaton L, Fowler J, Lewandowski G, Vaccarello L, Bell J, Reid G, de la Chapelle A. Hampel H, et al. Cancer Res. 2006 Aug 1;66(15):7810-7. doi: 10.1158/0008-5472.CAN-06-1114. Cancer Res. 2006. PMID: 16885385
Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A. Hampel H, et al. Among authors: lajeunesse j. J Clin Oncol. 2008 Dec 10;26(35):5783-8. doi: 10.1200/JCO.2008.17.5950. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809606 Free PMC article.
Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients.
Hampel H, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, LaJeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, de la Chapelle A, Frankel W, Penzone P, Cohn DE, Copeland L, Eaton L, Fowler J, Lombardi J, Dunn P, Bell J, Reid G, Lewandowski G, Vaccarello L. Hampel H, et al. Among authors: lajeunesse j. Cancer Res. 2007 Oct 1;67(19):9603. doi: 10.1158/0008-5472.CAN-07-2308. Cancer Res. 2007. PMID: 17909073 No abstract available.
[Medical escape games: experimenting with a new teaching method].
Larouche P, Sweeney K, Lajeunesse J. Larouche P, et al. Among authors: lajeunesse j. Can Med Educ J. 2024 Feb 29;15(1):78-79. doi: 10.36834/cmej.77290. eCollection 2024 Feb. Can Med Educ J. 2024. PMID: 38528889 Free PMC article. French.
The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC.
Dobischok S, Guh D, Marchand K, MacDonald S, Lock K, Harrison S, Lajeunesse J, Schechter MT, Oviedo-Joekes E. Dobischok S, et al. Among authors: lajeunesse j. Subst Abuse Rehabil. 2023 Nov 15;14:147-156. doi: 10.2147/SAR.S438451. eCollection 2023. Subst Abuse Rehabil. 2023. PMID: 38026787 Free PMC article.
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review.
Adams A, Blawatt S, Magel T, MacDonald S, Lajeunesse J, Harrison S, Byres D, Schechter MT, Oviedo-Joekes E. Adams A, et al. Among authors: lajeunesse j. Subst Abuse Treat Prev Policy. 2023 Sep 30;18(1):56. doi: 10.1186/s13011-023-00564-9. Subst Abuse Treat Prev Policy. 2023. PMID: 37777766 Free PMC article. Review.
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.
Oviedo-Joekes E, Dobischok S, Carvajal J, MacDonald S, McDermid C, Klakowicz P, Harrison S, LaJeunesse J, Chow N, Brown M, Gill S, Schechter M. Oviedo-Joekes E, et al. Among authors: lajeunesse j. BMC Health Serv Res. 2023 May 26;23(1):553. doi: 10.1186/s12913-023-09558-6. BMC Health Serv Res. 2023. PMID: 37237256 Free PMC article.
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review.
Adams A, Blawatt S, MacDonald S, Finnick R, Lajeunesse J, Harrison S, Byres D, Schechter MT, Oviedo-Joekes E. Adams A, et al. Among authors: lajeunesse j. Int J Drug Policy. 2023 Jul;117:104058. doi: 10.1016/j.drugpo.2023.104058. Epub 2023 May 8. Int J Drug Policy. 2023. PMID: 37182352 Free PMC article. Review.
21 results